About the study In the present study, researchers developed and validated an estimation model to provide individualized estimates of differences in one-year glycemic outcomes for GLP1-receptor agonists and SGLT2-inhibitors
The 2023 FDA review of 503A compoundable peptides moved CJC-1295 and ipamorelin into more restricted status, narrowing access
Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic neuropathy, using drugs that block the sympathetic nervous system (e.g., beta-blockers) or who experience recurrent hypoglycemia
In December 2024, JD Health began offering Mercks GLUCOPHAGE XR (Reduce Mass) online in China, enhancing access to metformin hydrochloride extended-release tablets for type 2 diabetes patients
Only studies that evaluated clinical, radiological, surgical, and histopathological findings were included
Despite the essential role of SLC25A39/40 in cell proliferation and the role of SLC25A39 in red blood cell development, how mitochondrial GSH import deficiency impairs cellular functions has never been investigated
